EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical outcomes and demographic profile of patients with anal cancer: A retrospective analysis from tertiary care center from Kashmir valley

Musaib Mushtaq, Uzma Rehman, Mushtaq Ahmad Sofi, Gaurav Singh Chauhan, Shahida Nasreen, Aasifa Andleeb, Kaneez Fatima

Asian Journal of Medical Sciences · 30.06.2026 · 17 (7) · 157-161

DOI: 10.71152/ajms.v17i7.5281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Medical Sciences, online erschienen am 30.06.2026. Verfasst von Musaib Mushtaq und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anal canal cancer is a rare gastrointestinal malignancy with limited published data from low- and middle-income countries. Aims and Objective: This study aimed to evaluate the clinicodemographic profile, treatment patterns, toxicity, and outcomes of anal canal cancer patients treated at a tertiary care center in North India. Materials and Methods: This retrospective observational study included patients with histologically confirmed squamous cell carcinoma anal canal treated at Sher-i-Kashmir Institute of Medical Sciences between January 2015 and December 2024. Data regarding demographics, clinical presentation, risk factors, staging (American Joint Committee on Cancer (AJCC 9th edition)), treatment modalities, radiotherapy techniques, acute toxicities (common terminology criteria for adverse events v5.0), treatment response, and disease status at last follow-up were analyzed using descriptive statistics.

Results

A total of 55 patients were included. The majority were aged >50 years (74.5%) with a female predominance (56.4%). Most patients presented with stage II disease (58.2%) and had good performance status (Eastern Cooperative Oncology Group 0–1, 89.1%). Definitive concurrent chemoradiation was administered to 89.1% of patients, and intensity-modulated radiotherapy (IMRT) was used in 84.3%. IMRT was associated with lower rates of grade ≥3 acute skin (20% vs. 46%) and gastrointestinal toxicity (18% vs. 33%) compared to 2D radiotherapy, while hematological toxicity was comparable. Complete response was achieved in 86.3% of patients. At the last follow-up, 95.1% of evaluable patients were alive and disease-free.

Conclusion

Definitive concurrent chemoradiation provides excellent disease control in anal canal cancer. IMRT significantly reduces severe acute toxicity and should be preferred in routine clinical practice.

Zitieren

APA

Mushtaq, M., Rehman, U., Sofi, M. A., Chauhan, G. S., Nasreen, S., Andleeb, A., & Fatima, K. (2026). Clinical outcomes and demographic profile of patients with anal cancer: A retrospective analysis from tertiary care center from Kashmir valley. Asian Journal of Medical Sciences, 17(7), 157-161. https://doi.org/10.71152/ajms.v17i7.5281

Vancouver

Mushtaq M, Rehman U, Sofi MA, Chauhan GS, Nasreen S, Andleeb A, et al. Clinical outcomes and demographic profile of patients with anal cancer: A retrospective analysis from tertiary care center from Kashmir valley. Asian Journal of Medical Sciences. 2026;17(7):157-161. doi:10.71152/ajms.v17i7.5281

BibTeX
@article{Mushtaq2026,
  author = {Mushtaq, Musaib and Rehman, Uzma and Sofi, Mushtaq Ahmad and Chauhan, Gaurav Singh and Nasreen, Shahida and Andleeb, Aasifa and Fatima, Kaneez},
  title = {Clinical outcomes and demographic profile of patients with anal cancer: A retrospective analysis from tertiary care center from Kashmir valley},
  journal = {Asian Journal of Medical Sciences},
  year = {2026},
  volume = {17},
  number = {7},
  pages = {157--161},
  doi = {10.71152/ajms.v17i7.5281}
}
Kostenlos starten →